Advertisement

WSAZ Now Desk | WV Chapter of the Alzheimer’s Association says new drug offers hope

Sharon Covert, the executive director of the WV Chapter of the Alzheimer's Association, discusses the new drug the FDA approved Monday for some patients.
Updated: Jun. 8, 2021 at 6:05 PM EDT
Email This Link
Share on Pinterest
Share on LinkedIn

CHARLESTON, W.Va. (WSAZ) - On Monday, the Food and Drug Administration approved a much-debated drug, called aducanumab, used in the early stages of Alzheimer’s to help slow the progression of the disease.

The drug, isn’t meant to reverse the disease, but instead help to slow cognitive decline.

Sharon Covert, the executive director of the WV Chapter of the Alzheimer’s Association, says although it will help a small percentage of patients, it offers hope for a disease where there was little.

Copyright 2021 WSAZ. All rights reserved.